Introduction {#s0001}
============

*Ferulago* W. Koch. (Apiaceae) is represented by approximately 50 taxa throughout the world and 35 taxa in Turkey, 18 of which are endemic. Therefore, Anatolia is considered to be the gene center of this genus (Güner et al. [@CIT0015]). *Ferulago bracteata* Boiss. & Hausskn. is also an endemic perennial species, grown only in Gaziantep, Southeastern Anatolia, Turkey (Peşmen [@CIT0033]; Troia et al. [@CIT0046]).

*Ferulago* species have been used in folk medicine for their aphrodisiac, digestive, tonic, sedative, antiseptic, carminative, and vermifuge properties as well as for the treatment of hemorrhoids, ulcers, snake bites, spleen diseases and headaches (Boulus [@CIT0006]; Demetzos et al. [@CIT0011]). Other than medicinal usage, they have been consumed as salad or spice due to their special odor, also as food for goats and deer (Erdurak [@CIT0012]).

Previous phytochemical studies indicated that coumarins are the most common metabolites on *Ferulago* species (Jimenez et al. [@CIT0019]). Coumarins have various biological activities such as anticancer (Lee et al. [@CIT0024]; Luo et al. [@CIT0025]), anti-inflammatory (Kwon et al. [@CIT0022]; Huang et al. [@CIT0017]), anticoagulant (Aoyama et al. [@CIT0003]; Hirsh et al. [@CIT0016]), antiadipogenic (Shin et al. [@CIT0040]), antitubercular (Chiang et al. [@CIT0008]), antihyperglycemic (Fort et al. [@CIT0013]; Tchamadeu et al. [@CIT0045]), antiviral (Venugopala et al. [@CIT0047]), antifungal (Chou et al. [@CIT0009]; Wang et al. [@CIT0048]), antibacterial (Rosselli et al. [@CIT0036]), antihypertensive (Crichton & Waterman, [@CIT0010]; Gantimur et al. [@CIT0014]), anticonvulsant (Luszczki et al. [@CIT0027]), antioxidant (Kim et al. [@CIT0021]; Basile et al. [@CIT0005]), neuroprotective (Wang et al. [@CIT0049]), and antidiabetic (Marles & Farnsworth [@CIT0028]; Patel et al. [@CIT0032]). This is the first report of isolation and structure elucidation study on the roots of *F. bracteata* to afford a new coumarin, peucedanol-2′-benzoate (**1**), along with nine known ones (**2--10**) and a sterol mixture (**11--12**). The α-amylase and α-glucosidase inhibitory activities of isolated coumarins were also evaluated. Coumarins may be a potential source of new antidiabetic agents and may also be used by peripheral tissues by improving insulin resistance and increasing glucose uptake (Zhang et al. [@CIT0052]). Peucedanol 7-*O*-β-[d]{.smallcaps}-glucopyranoside (Lee et al. [@CIT0023]), coumarin (1,2-benzopyrone) (Pari & Rajarajeswari [@CIT0031]) umbelliferone (Ramesh & Pugalendi [@CIT0034]), imperatorin (Adebajo et al. [@CIT0002]), psoralen, 5-methoxypsoralen, 8-methoxypsoralen, isooxypeucedanin, pabulenol, oxypeucedanin methanolate, oxypeucedanin hydrate (Shalaby et al. [@CIT0039]), isobergapten, pimpinellin, isopimpinellin, sphondin, scopoletin, phellopterin, byakangelicin and daucosterol (Zhang et al. [@CIT0052]) were isolated from various plants belonging to the Apiaceae family and were found to be antidiabetic. So, this may be a significant approach in the treatment of type 2 diabetes. This study is a first report on the isolation and characterization of the bioactive compounds from root extracts of *F. bracteata* and also reports α-amylase and α-glucosidase inhibitory activities of this species.

Materials and methods {#s0002}
=====================

General {#s0003}
-------

NMR spectra were recorded on a Varian Mercury Plus at 400 MHz for ^1 ^H NMR and 100 MHz for ^13 ^C NMR by using TMS as the internal standard. The solvents were CDCl~3~. HR-ESI-MS was performed on Agilent 6530 Accurate- Mass Q-TOF LC/MS. UV spectra were measured using Thermo Scientific Multiskan GO microplate and cuvette spectrophotometer. IR spectra were run on a Bruker VERTEX 70v FT-IR Spectrophotometer. Column chromatographies were performed on Silica gel 60 (0.063--0.200 mm, Merck) and Sephadex LH-20 (Fluka). TLC was carried out on pre-coated Kieselgel 60 F~254~ aluminum sheets (Merck).

Plant material {#s0004}
--------------

The roots of *F. bracteata* were collected in July 2014 from Gaziantep (C6 Gaziantep: Nurdağı Antep road 22. km, calcareous cliff rocks, 1642 m east of Turkey, Coordinates: 37° 11′ 226 N, 36° 57′ 792 E) and identified by Prof. Dr. Hayri Duman, a plant taxonomist in the Department of Biological Sciences, Faculty of Art and Sciences, Gazi University. A voucher specimen (No AEF 26676) is stored in the Herbarium of Faculty of Pharmacy, Ankara University, Turkey.

Extraction and isolation {#s0005}
------------------------

Air-dried roots of *F. bracteata* (450 g) were powdered and macerated three times with methanol for 8 h in a water bath not exceeding 45 °C (4 × 2 L) using a mechanical mixer at 300 rpm. Combined extracts were filtered and concentrated to dryness (60.94 g), then dispersed in methanol:water (1:9) and fractionated four times with 400 mL of dichloromethane, ethyl acetate, and *n*-butanol, respectively. Each fraction was concentrated to dryness, and 17.96 g dichloromethane, 2.44 g ethyl acetate, and 14.98 g of *n*-butanol fractions were obtained. Finally, 23.55 g of aqueous fraction remained. The roots (50 g) were grounded and macerated with 500 mL of distilled water for 8 h/3 days at 30 to 35 °C. This material was filtered and lyophilized to give aqueous extracts of 3.99 g roots.

As a result of the bioguided fractionation study, the effective dichloromethane extract was first submitted to a silica gel column (Merck 737, 70--230 Mesh) and eluted with a gradient of *n-*hexane:ethyl acetate (100:0 → 0:100, *v/v*) and ethyl acetate:methanol (100:0 → 0:100, *v/v*), and eight fractions (Fr. A--H) were obtained. Fr. A was subjected to a silica gel column, which was eluted with a mixture of *n-*hexane:ethyl acetate (95:5) and compounds **11** and **12** were obtained as a mixture (217 mg). Repetitive silica gel column chromatography with *n*-hexane:ethyl acetate (90:10 and 95:5) solvent system on Fr. B gave compound **2** (220 mg). Fr. C was applied to silica gel column eluting with *n*-hexane:ethyl acetate (85:15) and Sephadex LH-20 column eluting with ethyl acetate to give compounds **3** (125 mg) and **4** (130 mg). Eluting with *n*-hexane-ethyl acetate (90:10) over silica gel column of Fr. D gave compound **5** (400 mg) and Fr. E gave compounds **1** (320 mg), **6** (150 mg), and **7** (330 mg). Fr. F was eluted with 25% ethyl acetate in *n*-hexane and rechromatographed with 25% ethyl acetate in *n*-hexane on silica gel column to obtain compound **8** (110 mg). Fr. G was fractioned by column chromatography over silica gel using *n*-hexane:ethyl acetate mixtures (70:30 and 90:10) consecutively to obtain compound **9** (325 mg). Fr. H was submitted on a silica gel column using *n*-hexane:ethyl acetate (65:35) and the resulting fraction was chromatographed on silica gel column using *n*-hexane:ethyl acetate (90:10) to obtain compound **10**.

Peucedanol-2\'-benzoate (1) {#s0006}
---------------------------

White powder; IR *ν*~max~ (KBr) cm^−1^: 1702, 1623, 1565; UV *λ*~max~ (CH~2~Cl~2~) nm (log *ɛ*): 350 (4.20); ^1 ^H NMR (400 MHz, CDCl~3~) and ^13 ^C NMR (100 MHz, CDCl~3~) spectroscopic data, see [Table 1](#t0001){ref-type="table"}; HR-ESI-MS at *m/z* 367.1999 \[M-H\]^+^ (Calculated for C~21~H~19~O~6~ 367.1181).

###### 

^1 ^H NMR (400 MHz) and ^13 ^C NMR (100 MHz) data of **1** in CDCl~3~.

  No    *δ*~H~ (*J* in Hz)    *δ*~C~
  ----- --------------------- --------
  2                           161.38
  3     6.26 (d, 9.4)         112.37
  4     7.64 (d, 9.4)         143.62
  5     7.28 (s)              123.22
  6                           124.55
  7                           163.49
  8     6.80 (s)              98.01
  9                           155.84
  10                          112.71
  1′    3.38 (m)              29.67
  2′    5.16 (dd, 9.2, 7.3)   89.12
  3′                          82.93
  4′    1.72 (s)              22.16
  5′    1.71 (s)              21.38
  1′′                         165.40
  2′′                         131.04
  3′′   7.73 (m)              129.39
  4′′   7.32 (m)              128.27
  5′′   7.51 (m)              132.86
  6′′   7.32 (m)              128.27
  7′′   7.73 (m)              129.39

Antidiabetic activity {#s0007}
---------------------

### α-Amylase inhibitory activity {#s0008}

α-Amylase inhibitory activity was established in accordance with the reported method (Nampoothiri et al. [@CIT0030]) with slight modifications. One percent starch solution (100 µL) in 20 mM sodium phosphate buffer (pH 6.9 with 6 mM sodium chloride) and sample solutions (100 µL) were incubated at 25 °C for 10 min in 24-well microplate. After incubation, 100 µL α-amylase solution (0.5 mg/mL) was added to each well and the reaction mixtures were incubated at 25 °C for 10 min. In order to stop the reaction after the incubation, dinitrosalicylic acid color reagent (200 µL) was added and then the microplate was incubated in a boiling water bath for 5 min and cooled at room temperature. 50 µL was taken from each well and then was added to 96-well microplate. The reaction mixture was diluted by adding 200 µL distilled water and absorbance was measured at 540 nm. Each assay for all samples was carried out in triplicate. Percentage inhibitions of all samples were calculated using the equation at following: $$Inhibition~\left( \% \right) = \left( {1 - \frac{{\Delta A}_{\text{sample}}~}{{\Delta A}_{control}}} \right) \times 100$$

### α-Glucosidase inhibitory activity {#s0009}

α-Glucosidase inhibitory activity was established by using a 96-well microtiter plate in accordance with the described method (Tao et al. [@CIT0044]) with slight modifications. *p*-Nitro-phenyl-α-[d]{.smallcaps}-glucopyranoside (*p*-NPG) was used as the substrate and was prepared in 0.1 M potassium phosphate buffer (pH 6.8). α-Glucosidase (0.1 Unit/mL, enzyme solution) was dissolved in the same buffer. Samples were dissolved in dimethyl sulfoxide (DMSO) and all samples (20 µL) together with the enzyme solution (20 µL) were mixed in the plate. Afterwards, the substrate (40 µL) was added for initiation of the reaction and the mixture was incubated at 37 °C for 40 min. After incubation is complete, 0.2 M sodium carbonate (80 µL) in phosphate buffer (pH 6.8) was added to all wells in order to quench the reaction. The amount of released *p*-nitrophenol (pNP) was measured at 405 nm using a 96-well microplate reader. Each assay for all samples was carried out in triplicate. Percentage inhibition of all samples was calculated using the following equation: $$Inhibition~\left( \% \right) = \left( {1 - \frac{{\Delta A}_{\text{sample}}~}{{\Delta A}_{control}}} \right){\times\,}100$$

Statistical analysis {#s0010}
--------------------

All results are expressed as mean ± SE and differences between means were statistically analyzed using one-way analysis of ANOVA followed by Bonferroni's complementary analysis, with *p* \< 0.05 considered to indicate statistical significance.

Results and discussion {#s0011}
======================

Methanol extract of the roots of *F. bracteata* was fractionated using solvents with different polarities (*n*-hexane, dichloromethane, ethyl acetate, and *n*-butanol) and the obtained fractions were evaluated for their α-amylase and α-glucosidase inhibitory activities. The active dichloromethane extract was subjected to column chromatography over silica gel and Sephadex LH-20. As a result, a new coumarin, peucedanol-2′-benzoate (**1**), together with nine known ones, osthole (**2**) (Sajjadi et al. [@CIT0037]), imperatorin (**3**) (Muller et al. [@CIT0029]), bergapten (**4**) (Stevenson et al. [@CIT0042]), prantschimgin (**5**) (Sajjadi et al. [@CIT0038]), grandivitinol (**6**) (Abyshev et al. [@CIT0001]), suberosin (**7**) ([@CIT0043]), xanthotoxin (**8**) (Stevenson et al. [@CIT0042]), felamidin (Kilic et al. [@CIT0020]) (**9**), umbelliferone (**10**) (Singh et al. [@CIT0041]), and a sterol mixture consisted of stigmasterol (**11**), β-sitosterol (**12**) (Woldeyes et al. [@CIT0050]) ([Figure 1](#F0001){ref-type="fig"}) were isolated and identified.

![Chemical structures of compounds **1--12**.](IPHB_A_1414857_F0001_B){#F0001}

Peucedanol-2′-benzoate (**1**) was isolated as a white powder with the molecular formula of C~21~H~20~O~6~ as determined by the HR-ESI-MS at *m/z* 367.1999 \[M − H\]^+^ (Calcd for C~21~H~19~O~6~ 367.1181). The IR spectrum of **1** showed absorption bands for C = O groups (1702 cm^−1^) and -CH = CH- bonds (1623, 1565 cm^−1^). The ^1 ^H NMR spectrum of compound **1** displayed two AB type system protons at *δ*~H~ 6.26 and 7.64 (each 1 H, d, J = 9.4 Hz) which was attributed to the H-3 and H-4 protons of the coumarin nucleus. The two single aromatic proton signals at *δ*~H~ 7.28 and 6.80 were assigned to H-5 and H-8 protons. The ^13 ^C NMR spectrum revealed the presence of 9 carbons resonances including four methine \[*δ*~C~ 112.37 (C-3), 143.62 (C-4), 123.22 (C-5), 98.01 (C-8)\], three oxygenated quaternary \[*δ*~C~ 161.38 (C-2), 163.49 (C-7), 155.84 (C-9)\], and two non-oxygenated quaternary carbons \[*δ*~C~ 124.55 (C-6), 112.71 (C-10)\] for coumarin skeleton. Two tertiary methyl groups at *δ*~H~ 1.72 (3 H, *s*, H-4′), 1.71 (3 H, *s*, H-5′) and at *δ*~C~ 22.16 (C-4′), 21.38 (C-5′) with the hydroxyl group; an oxygenated methine at *δ*~H~ 5.16 (1 H, dd, J = 9.2/7.3 Hz, H-2′) and at *δ*~C~ 89.12 (C-2′); and a methylene at *δ*~H~ 3.38 (2 H, m, H-1′) and at *δ*~C~ 29.67 (C-1′) confirmed the 2′,3′-dihydroxy-3′-methyl butyl moiety. HMBC correlation ([Figure 2](#F0002){ref-type="fig"}) between H-1′ (*δ*~H~ 3.38) and C-6 (*δ*~C~ 124.55) suggested that it was attached to C-6 position. Characteristic signals of a benzoyl moiety were also exhibited, including a pair of 2 H at *δ*~H~ 7.73 (H-3″, H-7″) and 7.32 (H-4″, H-6″) and 1 H at 7.51 (H-5″) in the ^1 ^H NMR spectrum and aromatic carbons at *δ*~C~ 131.04 (C-2″), 129.39 (C-3″, C-7″), 128.27 (C-4″, C-6″), 132.86 (C-5″) with a carbonyl carbon at *δ*~C~ 165.40 (C-1″) in the ^13 ^C NMR spectrum. The linkage of the benzoyl group to the 2′,3′-dihydroxy-3′-methyl butyl moiety was deduced from the downfield shifted signal of H-2′ (*δ*~H~ 5.16) and C-2′ (*δ*~C~ 89.12). Thus, the structure of the compound **1** was characterized as peucedanol-2′-benzoate.

![Significant HMBC (→) correlations of compound **1**.](IPHB_A_1414857_F0002_B){#F0002}

The extracts and compounds **1--10**, obtained via bioassay-guided fractionation and isolation process, were evaluated for their *in vitro* α-amylase and α-glucosidase inhibitory activities. The IC~50~ values and inhibitory effects (%) were given in [Table 2](#t0002){ref-type="table"} and [Figure (3,4)](#F0003 F0004){ref-type="fig"}. Acarbose was used as a reference standard for both assays. Dichloromethane extract showed significant activity against α-glucosidase (IC~50~ 0.95 mg/mL) and among the tested compounds felamidin (IC~50~ 0.42 mg/mL) possessed the best inhibitory activity which were more potent than acarbose (IC~50~ 4.95 mg/mL). Suberosin, osthole, imperatorin, prantschimgin, peucedanol-2′ benzoate also showed α-glucosidase inhibitory activity (IC~50~ 0.89, 0.95, 1.23, 1.86, 3.24 mg/mL, respectively) which had lower effect than felamidin but stronger than acarbose. Among the tested compounds bergapten, xanthotoxin, and umbelliferone (IC~50~ 6.12, 5.38, and 9.32 mg/mL, respectively) showed lower activity than reference compound acarbose. Grandivitinol (IC~50~ 20.01 mg/mL) possessed the worst inhibitory activity. However, none of the extracts showed meaningful α-amylase inhibitory activity, while acarbose indicated 82.28% inhibition at a concentration of 1 mg/mL. These results indicate that felamidin was 11 times more effective than acarbose against α-glucosidase.

![*α*-Glucosidase inhibition (%) of extracts and fractions of roots from *Ferulago bracteata* at different concentrations. The different extracts and fractions were compared with acarbose and *p* \< 0.05 (p = 0.0004).](IPHB_A_1414857_F0003_B){#F0003}

![*α*-Glucosidase inhibition effects (%) of compounds **1--10**. The isolated coumarins were compared with acarbose and *p* \<0.05 (p = 0.0437).](IPHB_A_1414857_F0004_B){#F0004}

###### 

*α*-Glucosidase inhibitory activities of extracts, fractions and compounds **1--10**.

  Extracts/Fractions/Compounds   Concentration (µg/mL)   *α*-Glucosidase inhibition (%)   IC~50~ value (mg/mL)
  ------------------------------ ----------------------- -------------------------------- ----------------------
  Methanol extract               5000                    64.44 ± 1.47                     4.19
                                 2000                    51.42 ± 0.53                      
  Dichloromethane fraction       5000                    85.52 ± 0.38                     0.95
                                 2000                    74.19 ± 0.68                      
  Ethyl acetate fraction         5000                    58.04 ± 0.76                     4.20
                                 2000                    30.24 ± 0.75                      
  *n*-Butanol fraction           5000                    30.05 ± 1.63                     8.35
                                 2000                    12.18 ± 0.35                      
  Aqueous residue fraction       5000                    3.87 ± 1.28                      ND
                                 2000                    1.06 ± 0.75                       
  Aqueous extract                5000                    8.55 ± 1.92                      ND
                                 2000                    5\. 48 ± 1.23                     
  Peucedanol-2\'-benzoate        5000                    77.22 ± 0.44                     3.24
                                 2000                    66.86 ± 0.37                      
  Osthole                        5000                    93.31 ± 0.29                     0.95
                                 2000                    84.31 ± 1.72                      
  Imperatorin                    5000                    88.97 ± 0.88                     1.23
                                 2000                    63.07 ± 0.69                      
  Bergapten                      5000                    42.26 ± 0.43                     6.12
                                 2000                    39.71 ± 2.44                      
  Prantschimgin                  5000                    68.23 ± 0.39                     1.86
                                 2000                    51.95 ± 0.01                      
  Grandivitinol                  5000                    12.30 ± 0.36                     20.01
                                 2000                    7.84 ± 0.71                       
  Suberosin                      5000                    87.95 ± 1.07                     0.89
                                 2000                    81.58 ± 1.15                      
  Xanthotoxin                    5000                    45.76 ± 4.82                     5.38
                                 2000                    37.95 ± 8.64                      
  Felamidin                      5000                    94.57 ± 0.05                     0.42
                                 2000                    64.93 ± 2.06                      
  Umbelliferone                  5000                    10.27 ± 0.49                     9.32
                                 2000                    8.84 ± 0.02                       
  Acarbose                       5000                    50.81 ± 2.51                     4.95
                                 2000                    29.43 ± 1.71                      

Data are means ± SD of three replicates in each group.

To our knowledge, no previous studies have been reported on α-glucosidase and α-amylase inhibitory activities of *F. bracteata* and the isolated coumarins prantschimgin, peucedanol-2′-benzoate, felamidin, grandivitinol, and suberosin. Also, this is the first report on the phytochemical analysis of *F. bracteata*.

Our results are similar to the previous studies performed on related coumarins. Shalaby et al. ([@CIT0039]) found that imperatorin (at 1000 µg/mL α-glucosidase inhibition% was found to be 69.66 ± 3.67 and we found an inhibition of 88.97 ± 0.88% at a concentration of 5000 µg/mL) showed appreciable antidiabetic activity. Comparing these results with previous studies in which α-glucosidase IC~50~ value of umbelliferone was found to be 7.79 ± 0.11 μg/mL, we have found a higher inhibitory activity with 9.32 mg/mL (Ramith et al. [@CIT0035]). Comparing these results with a previous study in which α-glucosidase IC~50~ value of umbelliferone was 0.547 mg/mL at 0.5 mg/mL, the inhibitory activity that we found was higher (Ayyasamy & Rajamanickam 2015). Luo et al. ([@CIT0026]) reported that α-glucosidase inhibitory activity of bergapten, xanthotoxin, and imperatorin has been too low to compare to that of acarbose. In our study, it was determined that bergapten and xanthotoxin showed similar effects, however, imperatorin was more effective than acarbose. In spite of the advances in biomedical science and the introduction of new treatment ways, diabetes mellitus has been a major cause of end-stage renal disease, new-onset blindness, and cardiovascular diseases, all of which cause excess mortality and morbidity in people with diabetes (Islam et al. [@CIT0018]). Medical herbs are generally rich in phenolic compounds, such as phenolic acids, flavonoids, tannins, stilbenes, lignans, coumarins, and lignins (Celik et al. [@CIT0007]). One of the therapeutic approach for treating diabetes is to reduce the postprandial hyperglycemia and this is made by delaying the absorption of glucose via the inhibition of the carbohydrate-hydrolyzing enzyme α-glucosidase in the digestive tract. Inhibitors of intestinal α-glucosidase have been utilized in the treatment of non-insulin-dependent diabetes mellitus and represented at the large ratio of antidiabetic drug market (Yin et al. [@CIT0051]). The tested extracts and isolated compounds are rich in phenolic compounds, as well as in coumarins, which may contribute to its *in vitro* antidiabetic effect. In addition, this study suggests that the glucose-lowering effect of these plants can be due, at least in part, to the inhibition of α-glucosidase. Also, investigations are warranted to define the active principles and elucidate other possible mechanism(s) of action. Natural products are still considered as potential sources for drug exploration and play a significant role in drug development programs. Furthermore, many medicinal plants could be rich sources of bioactive chemicals that are importantly free from undesired adverse effects and show powerful pharmacological activities.

Conclusions {#s0012}
===========

In conclusion, the present study demonstrated that among the compounds isolated from CH~2~Cl~2~ fraction of *Ferulago bracteata* roots, coumarins were determined the main chemical constituents of this fraction. The most potent compounds found were felamidin and suberosin, respectively. Thus, *F. bracteata* along with its isolated compounds could be used for further studies on the development of novel preventive or therapeutic agents for the treatment of diabetes.
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